UNCA
Coronel Oviedo, Paraguay
Location status: Recruiting
Location contact
Julieta Mendez
CONTACT
NCT Number: NCT07529119
This randomized clinical trial evaluates the effect of a mango and chia-based beverage on gut microbiota modulation in 100 Paraguayan children aged 8-16 years with obesity. Participants will consume the intervention beverage for 6 weeks. Fecal samples will be collected before and after each intervention to analyze microbiota composition using 16S rRNA sequencing. This study aims to characterize the gut microbiota of Paraguayan children for the first time and assess whether this functional beverage can positively modulate intestinal bacteria as a potential strategy to address childhood obesity, which affects 1 in 3 school-age children in Paraguay.
Interested in participating?
Request Info8 year–16 year
All sexes
Interventional
Not applicable
Coronel Oviedo, Paraguay
Location status: Recruiting
Julieta Mendez
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
100 children aged 8-16 years from Paraguay, stratified by BMI (with/without excess weight).
Exclusion criteria
Allergyc to mango or chia
Mango juice drink for 6 weeks 200 ml daily, 5 days a week
Mango and chia juice drink for 6 weeks, 200 ml daily 5 days a week
Time frame: Baseline and after 4 weeks
Gut microbiota composition analysis (16S rRNA sequencing)
Time frame: Baseline and after 4 weeks
Measure of weight
Contact information is provided by the study sponsor or research team.
Universidad Nacional de Caaguazu
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724522
Body Weight, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT07075601
Cardiac Surgery, Cardiovascular Diseases
Toulouse, France
View Trial DetailsNCT06347770
Microbiota, Postoperative Recovery
Guangzhou, Guangdong, China
View Trial DetailsNCT07460856
Body Weight, Glucose Metabolism Disorders
Québec, Quebec, Canada
View Trial Details